GLPG (glpg.com) יחס שווי שוק לשווי בספרים

Galapagos NV (GLPG) relies on external contractors for molecule production and research. This chart reflects the asset's price action, where the key indicator is 0.48. The business is currently struggling with customer churn due to the loss of patent protection while awaiting approval for new drugs. Simultaneously, Galapagos NV (GLPG) is implementing a decentralized approach by creating a network for the manufacturing of CAR-T therapies directly within medical centers.

A stable liquidity reserve from previous transactions allows Galapagos NV to focus on CAR-T therapy, which directly impacts the extent to which market capitalization exceeds book value. This ratio compares the business's market value with its net assets, enabling investors to determine the degree of company overvaluation or undervaluation relative to actual capital in a real-time assessment.